Community Bank’s Atossa Therapeutics ATOS Stock Holding History

Community Bank’s Portfolio ATOS Stock Details ATOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-98	Closed	-$2K	–	439
2021 Q4	$2K	Hold	98	–	–	﹤0.01%	425
2021 Q3	$5K	Hold	98	–	–	﹤0.01%	426
2021 Q2	$9K	Hold	98	–	–	﹤0.01%	405
2021 Q1	$3K	Buy	+98	New	+$3.58K	﹤0.01%	444

Other funds holding ATOS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Community Bank's ATOS Position: Q1 2022 in Review

Community Bank sold out of Atossa Therapeutics (ATOS) in Q1 2022, closing a stake of 98 shares — an estimated $2K sold.

Community Bank first reported a position in ATOS in Q1 2021 and held it in 4 quarters. The position peaked at $9K in Q2 2021. 83 funds tracked by Wall St. Rank hold ATOS as of Q1 2022.

Community Bank reported no remaining Atossa Therapeutics position as of Q1 2022 after selling out during the quarter.
Community Bank sold 98 Atossa Therapeutics shares in Q1 2022, an estimated $2K.
Community Bank first reported a position in Atossa Therapeutics in Q1 2021 and held it in 4 quarters.
Community Bank's Atossa Therapeutics position peaked at $9K in Q2 2021.
83 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q1 2022.

Based on Community Bank's 13F filing for Q1 2022, filed 5 May 2022.